Heparin
- TRADE NAMES: Calcilean; Calciparin; Caprin; Hep-Flush (Wyeth); Hep-Lock; Hepalean; Heparin-Leo; Heparine; Liquemin; Uniparin; Viaflex (Baxter)
- INDICATIONS: Venous thrombosis, pulmonary embolism, intravascular coagulation, peripheral arterial embolism
- CLASS: Anticoagulant (antithrombotic), Heparinoid
- HALF-LIFE: 2 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Acenocoumarol, Aliskiren, Antihistamines, Aspirin, Balsalazide, Bivalirudin, Butabarbital, Ceftobiprole, Dabigatran, Danaparoid, Defibrotide, Desvenlafaxine, Iloprost, Inotersen, Nandrolone, Nicotine, Nitroglycerin, Palifermin, Piperacillin/Tazobactam, Salicylates, Tirofiban, Warfarin
PREGNANCY CATEGORY: C
Investigated for treating COVID-19.
A higher incidence of bleeding has been reported in patients over 60 years of age, especially women.
Contra-indicated in patients with severe thrombocyopenia.
Please login to see the rest of this drug profile
SKIN.
HAIR.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OTHER.
Page last updated 12/12/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric